Pharmaceutical
Benchmarking global, regional and local pharmaceutical practices delivers unique insight and value to IMS's clients

IMS helps clients improve their decision making through a unique continuum of capabilities - unmatched information, analytics and consulting-focused solely on the healthcare marketplace, working seamlessly together as a team to provide the answers decision-makers need. From pipeline to marketplace, from every perspective, IMS understands the dynamics of global healthcare...and how to help clients develop, market and sustain breakthrough therapies that improve millions of lives around the world.

IMS works with nearly every pharmaceutical company on Earth - as well as helping a large number of biotechnology firms, public health agencies, and academic organisations. Clients realise that no competitor can approach the depth and breadth of IMS's intelligence - and the ability to apply it to the challenges they face each day:

Sales Force Effectiveness
IMS integrates information and expertise to empower client sales teams to optimise operations and work more productively. A keen focus on better segmentation and getting the right information to the right people yields more effective call planning, optimal sales force sizing, and enhanced performance, compensation and territory management.

Portfolio Optimization
IMS evaluates the mix of products in the portfolio and pipeline, helping clients determine which therapy areas to enter, which products to develop and licence, how to monitor markets and assess performance, and how to identify promising co-marketing partners or acquisitions.

Launch Management
Global launch visibility enables clients to maximise early results and sustain performance of new products. IMS drives decision-making, forecasts results, optimises strategies, the designs the right promotional mix, monitors uptake and recommends necessary course corrections.

Brand Management
From product launch to patent expiration, IMS helps clients maximise brand performance, build brand equity and minimise risk. Supporting key brand decisions through qualitative and quantitative disciplines, it assesses advertising and promotional effectiveness and prescribing behaviour, and helps drive marketing and sales strategies for enhanced returns.

Managed Care
IMS clarifies the impact of managed care, including the effects of higher co-pays, multi-tier formularies, Medicare reform and cost shifts to consumers. Offerings also enable clients to unlock product potential and assess contract management, rebate validation, performance tracking and physician affiliation.

Consumer Health
IMS delivers a better understanding of over-the-counter consumer purchasing dynamics and promotional impact by assessing segmentation and sales force management, business plans, market opportunities and performance mangement. And we help pharma clients evalutate OTCs impact on their prescription products.

For further information